Elevance Health Aktie News

Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and strong double-digit top-line growth despite sector headwinds. Recent FQ3 2025 results showed a double-beat, with revenue up 12% year-over-year and EPS surpassing analyst estimates, signaling a turnaro...

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung shares are finally starting to benefit from AI enthusiasm. Elevance's share price declined by 16%, making it our largest negative contributor.

Health insurance company stocks rose again Wednesday before the Thanksgiving holiday amid hope the Trump administration and Congress can agree on an extension of tax credits for those who buy individual coverage under the Affordable Care Act.

Global Equity ETF posted a return of 1.80% in the third quarter of 2025. Leading contributors in the First Eagle Global Equity ETF this quarter included Oracle, Alphabet Inc. Class C, Samsung Electronics Co Ltd Pfd Non-Voting, Barrick Mining and Newmont Corporation. The leading detractors in the quarter were Elevance Health, Philip Morris, Shimano, Comcast Corporation Class A and Salesforce.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members.

Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic interest in Vantage Studios, while Ubisoft retains exclusive control and consolidation.

Merck offers strong dividend growth, a robust drug pipeline, and strategic acquisitions, positioning it well beyond Keytruda's patent expiration. MRK's 3.9% dividend yield, low payout ratio, and A+ credit rating support its 14-year dividend growth streak and future income potential. Elevance Health faces near-term headwinds but boasts a large consumer base, efficiency initiatives, and a 13-year...

Rising Dividend Fund A Shares (without sales charge*) posted a return of 9.70% in third quarter 2025. Leading contributors in the First Eagle Rising Dividend Fund this quarter included Alphabet Inc. Class A, Oracle Corporation, TE Connectivity Ltd., Samsung Electronics Co Ltd Pfd Non-Voting and C.H. Robinson Worldwide, Inc. The leading detractors in the quarter were Comcast Corporation Class A,...